Abstract:Objective To quantify the changes in blood glucose, blood lipids, blood pressure, and the intima-media thickness (IMT) of large arteries in patients with new-onset type 2 diabetes mellitus who received either intensive multifactorial treatment or conventional treatment. Methods Two-hundred and ten patients with new-onset type 2 diabetes mellitus were randomly assigned to two groups: an intensive treatment group ( n =110) and a conventional treatment group ( n =100). Fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), blood pressure, blood lipids [total cholesterol (TC), triglyceride (TG), low-density lipoprotein C (LDL-C), and high-density lipoprotein C (HDL-C)], and IMTs of large arteries (carotid, iliac, and femoral arteries) were determined before and at one and two years after starting treatment. The patients in the conventional treatment group received routine diabetes management in our outpatient department. Targets were established for patients in the intensive treatment group. Their blood glucose, blood lipids, and blood pressure levels were regularly monitored and therapeutic regimens were adjusted for those whose measurements did not meet the target values until all the parameters met the established targets. Within-group and between-group differences were evaluated. Results A significantly greater percentage of patients in the intensive treatment group had LDL-C levels that reached the target value one year after starting treatment than those in the conventional treatment group (52.04% vs. 33.33%, P <0.05). No significant differences were found between groups for FBG, HbA1c, blood pressure, TG, TC, or HDL-C. The percentages of patients with TG (51.02% vs. 34.48%), TC (52.04% vs. 33.33%), and LDL-C (61.22% vs. 43.67%) who met the respective target values in the intensive treatment group were all significantly higher than the corresponding percentages in the conventional treatment group two years after starting treatment ( P <0.05). There were no significant differences in the percentages of patients with FBG, HbA1c, and blood pressure values meeting the respective targets between the groups at the two-year follow-up. One year after starting treatment, the LDL-C level, diastolic blood pressure (DBP), and the IMTs of the femoral and iliac arteries of the intensive treatment group were significantly lower compared to those of the conventional treatment group ( P <0.05), although there was no significant difference in other metabolic parameters. Two years after starting treatment, the TC, LDL-C, blood pressure [systolic blood pressure (SBP) and DBP], and the IMTs of the carotid and femoral arteries of the intensive treatment group were significantly lower than those of the conventional treatment group ( P <0.05). No significant differences in other metabolic parameters existed between the two groups two years after starting treatment. Conclusions Early comprehensive and intensive treatment of type 2 diabetes mellitus can delay or even reverse the increase in IMT of large arteries. Lowering blood pressure and blood lipid regulation in patients with type 2 diabetes mellitus have great significance in decreasing the risk of diabetes-related macrovascular lesions.

Effect of Vitamin E on Subclinical Atherosclerosis in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

Subclinical atherosclerosis evaluated by high resolution ultrasonography in patients with newly diagnosed type 2 diabetes mellitus un-dergoing intensive treatment

Effects of four regimens on subclinical atherosclerosis in newly diagnosed type 2 diabetic patients

Effect of Multifactorial Intervention on Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetes

Effect of isoflavone et al complex antioxidant on the blood lipid metabolism in patients with type 2 diabetes

Risk Factors for the Progress of Subclinical Atherosclerosis in Newly Diagnosed Type 2 Diabetics with Multifactorial Intervention

Vascular Endothelial Dysfunction in Patients with Newly Diagnosed Type 2 Diabetes and Effects of 2-Year and 5-Year Multifactorial Intervention

Effect of vitamin D supplementation on cardiovascular risk in type 2 diabetes

Effect of Intensive Treatment on Subclinical Atherosclerosis in Patients with Newly Diagnosed Type 2 Diabetes Mellitus by High Resolution Ultrasonography

Impact of Multifactorial Intervention on Subclinical Atherosclerosis in Patients with Newly-diagnosed Type 2 Diabetes

Impact of Vitamin E Supplementation on Blood Pressure and Hs-CRP in Type 2 Diabetic Patients | doi: 10.5681/hpp.2012.009

Effect of oral vitamin E supplementation on lipid profile in diabetes mellitus: evidence based case report

Effects of Vitamin D3 Supplementation Combined with Standardized Hypoglycemic Regimen on Islet Β Cell Function and Macrovascular Complications in Newly Diagnosed Type 2 Diabetes Mellitus

Effects of complex antioxidant on the expression of inflammatory cellular factor under glucose load in patients with type 2 diabetes mellitus

Effect of Intensive Insulin Therapy on Vascular Endothelial Function in Newly Diagnosed Type 2 Diabetes Patients

The Effect of Vitamin D Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: An Updated Systematic Review and Meta‐Analysis of Clinical Trials

Effects of Multifactorial Intervention of Metabolic Syndrome in Newly-Diagnosed Type 2 Diabetics

Effects of vitamin D supplementation on the regulation of blood lipid levels in prediabetic subjects: A meta-analysis

Supplementation with Magnesium and Vitamin E Were More Effective Than Magnesium Alone to Decrease Plasma Lipids and Blood Viscosity in Diabetic Rats